bromopyruvate has been researched along with Infections, Staphylococcal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Imperi, F; Pisa, F; Visca, P | 1 |
Boradia, VM; Chopra, S; Das, S; Dasgupta, A; Gani, Z; Kumar, A; Patidar, A; Raje, CI; Raje, M; Singh, AK; Thakare, R | 1 |
2 other study(ies) available for bromopyruvate and Infections, Staphylococcal
Article | Year |
---|---|
The antimetabolite 3-bromopyruvate selectively inhibits Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Antimetabolites; Biofilms; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pyruvates; Staphylococcal Infections; Staphylococcus aureus | 2019 |
Repurposing ethyl bromopyruvate as a broad-spectrum antibacterial.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Repositioning; Enzyme Inhibitors; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating); Mice, Inbred BALB C; Microbial Viability; Mycobacterium tuberculosis; Pyruvates; Staphylococcal Infections; Staphylococcus aureus; Transferrin; Treatment Outcome | 2019 |